𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SIRT1 downregulation: A novel therapeutic strategy for pancreatobiliary cancers

✍ Scribed by Vikas Dudeja; Rohit K. Chugh; Veena Sangwan; Nameeta Mujumdar; Daniel Borja-Cacho; Rajinder K. Dawra; Selwyn M. Vickers

Book ID
113680161
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
109 KB
Volume
211
Category
Article
ISSN
1072-7515

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sirtuin-3 (SIRT3), a novel potential the
Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer
✍ Turki Y. Alhazzazi; Pachiyappan Kamarajan; Nam Joo; Jing-Yi Huang; Eric Verdin; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 455 KB

## BACKGROUND Several sirtuin family members (SIRT1-7), which are evolutionarily conserved NAD-dependent deacetylases, play an important role in carcinogenesis. However, their role in oral cancer has not yet been investigated. Therefore, the objective of this study was to investigate whether sirtui

PELP1: A novel therapeutic target for ho
PELP1: A novel therapeutic target for hormonal cancers
✍ Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K. Vadlamudi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 161 KB

## Abstract Recent studies implicate that the estrogen receptor (ER) coregulator proline‐, glutamic acid‐, and leucine‐rich protein (PELP) 1 as playing critical roles in ER‐genomic, ER‐nongenomic, and ER‐signaling cross talk with growth factor signaling pathways. PELP1 expression is deregulated in